Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roll-over trial of telaprevir + Pegasys + Copegus in prior control-group HCV genotype 1 failures
2009-012613-21Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of telaprevir in chronic hepatitis C virus infection, sponsored by Janssen Pharmaceutical. Primary endpoint: plasma HIV RNA quantification. Started Dec 2009; status: completed.
02
Drugs
telaprevir
03
Conditions
chronic hepatitis C virus infection
Beyond the preview
Go deeper on 2009-012613-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012613-21.